Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. - Wikidata - awgldk - TriplyDB

Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.

Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.

http://www.wikidata.org/entity/Q46433135

about

Pharmacological treatments for fatigue associated with palliative care Pharmacological treatments for fatigue associated with palliative care Interventions for fatigue management after traumatic brain injury Pharmacological treatments for fatigue associated with palliative care: executive summary of a Cochrane Collaboration systematic review Fatigue Management in Multiple Sclerosis Multiple sclerosis Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue Approved and investigational uses of modafinil : an evidence-based review Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment Efficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: a systematic review and meta-analysis Drugs for sleep disorders: mechanisms and therapeutic prospects The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders.Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: exercise, education, and medication Body temperature is elevated and linked to fatigue in relapsing-remitting multiple sclerosis, even without heat exposure.Fatigue in cancer: a review of literature Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment Relationship between depression, fatigue, subjective cognitive impairment, and objective neuropsychological functioning in patients with multiple sclerosis.Effects of multidisciplinary rehabilitation on chronic fatigue in multiple sclerosis: a randomized controlled trial New approaches in the management of multiple sclerosis.An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis.Modafinil in the treatment of debilitating fatigue in primary biliary cirrhosis: a clinical experience.Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants.Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.Treatment of fatigue in multiple sclerosis patients: a neurocognitive approach.Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women.Treatment of symptoms in multiple sclerosis.Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations Origin of fatigue in multiple sclerosis: review of the literature.Fatigue in neuroimmunological diseases.Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis.Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial.Fatigue in palliative care patients -- an EAPC approach.Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.Treatment of fatigue in multiple sclerosis: a systematic review of the literature.The treatment of fatigue.Fatigue and sleep-disordered breathing in multiple sclerosis: a clinically relevant association?Disease-modifying agents for multiple sclerosis: recent advances and future prospects.Effect of eszopiclone on sleep disturbances and daytime fatigue in multiple sclerosis patients.Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA.

P2860

Q24187756-4B6F3B25-8312-44CC-931C-0BB523048BED Q24236457-5F160FF7-EF5E-4873-8F36-17EFE29E7207 Q24245645-43A9123A-15F6-4F62-9BBB-B53E7DC1BF94 Q26749413-0F35EABF-9370-4F63-B59B-AE60AC5BF676 Q26752946-6F860788-090D-4E2B-86C5-15D88F9C3696 Q26995437-2E173549-F154-4262-9F57-A720F6F23CE8 Q27001628-58497472-0DB6-4060-B1CC-E7C15B7D1B78 Q28073849-9EAA4320-BC95-4A07-A1C9-DE7BBBF5454D Q28291968-9331CFCD-E005-4338-AD69-20B3CAC61F92 Q28301691-4F8BB862-4861-41ED-AF9A-6465C0691A7C Q28535752-04707EAF-12E8-4F53-8252-57098207DE2A Q30498393-0431B689-00A3-459C-A21E-63F9C7A97C5C Q30917626-9366F6CF-7709-4387-AEAC-44790F88A27A Q33735739-7987C52C-5746-4EC7-B9E8-232FE0A4841E Q33807332-DD0B944E-E6A9-493F-9ED7-F886E2C64BA3 Q33915622-20357A65-2BF9-4FB1-823B-344EB9D53FEF Q34021881-BD280CF5-95F7-451E-A413-9681D5C3C46B Q34102803-20ED7B42-42A7-4359-AFEB-1805FFF71E57 Q34214944-16CF67F1-1612-4616-8569-DBDF3D55A103 Q34389528-25F9E53B-CE40-4467-8888-CE6954E31E13 Q34608494-2E3C9035-9FA2-42B3-9EF7-17C2EDC64EDC Q34904107-03243CE2-9881-4749-AD91-66D699E76557 Q34985957-91CBC3BB-AA6F-4EA0-AC80-BE25E04D3195 Q35018491-83B1FDCC-ED71-4BAC-8ACA-8AEEF063E062 Q35390868-A4FB197A-79B6-4C19-A786-E128968E534A Q35937981-F5D4C240-E2F1-4628-BB6C-E8E8292467E7 Q36474348-4D144E20-8F40-45C8-BAD1-BCB8478484D0 Q36628420-724C9E8A-D247-4DDB-8E49-4BAC33748D63 Q36780439-91470617-7E0C-4D96-869D-02E774726748 Q36822048-7F702D21-5BB3-40A3-A9C6-DDE35F5B4922 Q36889694-7372C552-8191-4F0B-A8B6-4548C92A05EE Q36917907-68221EF6-3145-434E-B92B-3E974F29B38A Q37063833-2C0B0A24-278E-42E6-84CD-26ED1D1BD423 Q37089253-662424E1-EE73-4269-9CFB-52AE2DE215C1 Q37100322-89FED3A2-A4A6-4F3F-996D-AE11F3C19807 Q37238934-236CEA50-6A3E-4E02-8A4F-3B13BEADAC32 Q37285887-AE2B2007-55B5-49E8-96A4-075F7DF3BF1B Q37328280-12C89942-E9F2-47D2-80D5-3BE30A4A8CE7 Q37442056-62A8A85D-73E7-49C8-A5E3-E2B917947B1F Q37548284-BB79B0B5-A6CB-4914-87AB-ACD9AEBA67DF

P2860

Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.

http://www.wikidata.org/entity/Q46433135

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.

@en

type

label

Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.

@en

prefLabel

Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.

@en

P1433

Q46433135-7F42F70C-BA26-48FA-80B5-F03DC03E3123

P1476

Q46433135-0D040860-9732-43E0-A937-C318C3C20AE8

P2093

Q46433135-33D43B92-4F46-4F1C-8A86-151745F498D1

Q46433135-445A3E14-B95B-48B8-8E65-4339E19D64B3

Q46433135-51C9696F-1391-45ED-8B2A-1B585986ED4E

Q46433135-605D3174-433A-4092-BC63-A8C29333DA64

Q46433135-7B5CBB76-1B2D-4867-B30A-2A9ACA7F7F78

Q46433135-A629E1E8-67C8-4BBE-8095-ABE013EB35CD

Q46433135-B079D0EE-8212-42E6-B4FA-62790D637900

Q46433135-B502EAFF-E4F8-458B-971E-86D388BC2BE5

Q46433135-CBBFAD32-8FC0-4DBC-A9F9-123F53CFF9AD

Q46433135-E95D468F-E967-48B0-B810-8BD1DC846D3D

P304

Q46433135-686FCF6F-2234-4DB5-9165-2CE6F9AA474C

P31

Q46433135-6E0DCFA0-85AB-4C8A-B6E8-7D9D8F16462D

P356

Q46433135-06FF217B-9160-4D63-9976-327A1385F6DD

P407

Q46433135-7A5E4D02-5D6F-4143-8CCE-1C3901584171

P433

Q46433135-FBA84B05-DDE6-438B-8BFC-FD8B86054864

P478

Q46433135-DCA415EA-1465-4444-A9C8-19C3EB0ECE8C

P577

Q46433135-A0E3F389-08D7-4BBE-B73C-5FA1F8E91E19

P698

Q46433135-0A68B246-CE1B-4E91-BCE5-9892912B866D

P921

Q46433135-34372F1C-AF10-4FB0-8C0F-3632FF3136AE

Q46433135-518EB189-5781-4F9C-857A-68D5DA957FF1

P356

01.WNL.0000158272.27070.6A

P1433

P1476

Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.

@en

P2093

B Stankoff

http://www.w3.org/2001/XMLSchema#string

C Confavreux

http://www.w3.org/2001/XMLSchema#string

C Lubetzki

http://www.w3.org/2001/XMLSchema#string

E Waubant

http://www.w3.org/2001/XMLSchema#string

French Modafinil Study Group

http://www.w3.org/2001/XMLSchema#string

G Edan

http://www.w3.org/2001/XMLSchema#string

J Pelletier

http://www.w3.org/2001/XMLSchema#string

L Rumbach

http://www.w3.org/2001/XMLSchema#string

M Clanet

http://www.w3.org/2001/XMLSchema#string

M Debouverie

http://www.w3.org/2001/XMLSchema#string

P304

1139-1143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/01.WNL.0000158272.27070.6A

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15824337

http://www.w3.org/2001/XMLSchema#string

P921